Navigation Links
All-Oral Combination Study with PSI-7977 for HCV Genotypes 1, 2 and 3 Initiated
Date:5/26/2011

Act of 1995: Statements in this press release that are not historical facts are "forward-looking statements," that involve risks, uncertainties, and other important factors, including, without limitation, the risk of cessation or delay of any of the ongoing or planned clinical trials and/or our development of our product candidates, the risk that the results of previously conducted studies involving our product candidates will not be repeated or observed in ongoing or future studies involving our product candidates, the risk that our collaboration with Roche will not continue or will not be successful, and the risk that any one or more of our product candidates will not be successfully developed and commercialized. For a discussion of risks, uncertainties, and other important factors, any of which could cause our actual results to differ from those contained in the forward-looking statements, see the section entitled "Risk Factors" in our Annual Report on Form 10-K for the fiscal year ended September 30, 2010 and our Quarterly Reports on Form 10-Q filed with the Securities and Exchange Commission and discussions of potential risks, uncertainties, and other important factors in our subsequent filings with the Securities and Exchange Commission.


'/>"/>
SOURCE Pharmasset, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Ground-Breaking Combination of All-Oral Agents Demonstrates Potential as Hepatitis C Treatment Regimen
2. Ardea Biosciences Provides Additional Results From a Phase 2b Study of Lesinurad in Combination With Allopurinol at the Annual European Congress of Rheumatology
3. Nexavar in Combination with Chemotherapy Improves Progression-Free Survival in Patients with Advanced Breast Cancer in Phase 2 Study
4. ViroPharma and Halozyme Announce Collaboration for Combination of Recombinant Human Hyaluronidase Enzyme (rHuPH20) Technology with C1 Esterase Inhibitor
5. Pearl Therapeutics Highlights Its Porous Particle Cosuspension Platform, Demonstrating Universal Applicability Across Multiple Drug Classes and Combination Products
6. Particle Sciences and Celanese EVA Performance Polymers Collaborate to Accelerate Drug-Eluting Device Combinations
7. Jennerex and Green Cross Announce Publication of Positive Clinical Data of JX-594 in Combination With Sorafenib in Advanced Liver Cancer
8. Merrimack Pharmaceuticals Announces that Recruitment is Open in a Phase 1 Combination Study of MM-111 with Multiple Treatment Regimens in HER2 Positive Patients
9. New Interim Data About Combination Oral Contraceptives
10. Syndax Announces Start of NCI Sponsored Phase 2 Study of Entinostat in Combination in Triple Negative Breast Cancer
11. Bayer and Onyx Begin Enrollment in Phase 3 Trial of Nexavar in Combination With Chemotherapy Agent Capecitabine for Patients With Advanced Breast Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/3/2015)... March 3, 2015 Registration is officially open for ... 20-21, 2015 at the Shenzhen Convention & Exhibition Center. The ... the latest to join the MEDTEC China family of events. ... manufacturing, aims to better serve the South China ... what is an important region for China,s ...
(Date:3/3/2015)... 3, 2015 Today, the Partnership for ... America,s biopharmaceutical research companies, unveiled a redesigned ... provide patients and caregivers with faster, easier access ... private patient assistance programs. Since ... platform to engage, educate and empower patients and ...
(Date:3/3/2015)... -- The eleventh annual Tucson Symposium will be held March ... scientists, academics, oncologists and pathologists will gather to debate ... outcomes in patient treatments that may significantly affect the ... Medical Systems, Inc. (Ventana), a member of the ... the Hilton El Conquistador in Tucson, Arizona ...
Breaking Medicine Technology:Pre-registration Open for 2015 MEDTEC China South 2Pre-registration Open for 2015 MEDTEC China South 3Partnership for Prescription Assistance Relaunches Website with New Features for Patients and Caregivers 2Global scientific collaborators to explore latest pathology and oncology advancements at Tucson Symposium 2
... Cynosure, Inc. (Nasdaq: CYNO ), a leader ... non-invasive aesthetic applications, today announced that two of its ... have received key international regulatory clearances. ... the sale in Canada of the company,s SmoothShapes® XV ...
... 2011 Unilife Corporation ("Unilife" or the ... announced that it remains on schedule to commence initial ... and commence sales to pharmaceutical customers by the end ... Company successfully commissioned the cleanrooms at its state-of-the-art production ...
Cached Medicine Technology:Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products 2Cynosure Receives International Marketing Clearances for New Cellulite, Laser Lipolysis Products 3Unilife on Schedule to Fill Initial Orders for Unifill Syringe 2Unilife on Schedule to Fill Initial Orders for Unifill Syringe 3
(Date:3/3/2015)... 03, 2015 OncLive® and Indiana ... joined forces to share news about the center’s ... collaboration is part of OncLive’s Strategic Alliance Partnership ... editorial and marketing teams will partner with the ... cancer center, to highlight accomplishments. They include the ...
(Date:3/3/2015)... (PRWEB) March 03, 2015 Celestix ... connectivity solutions, today announced the global availability of ... It delivers the world’s most deployed platform for ... Server 2012 R2. This new release enables organizations ... access platform from a single HTML 5 web ...
(Date:3/3/2015)... 2015 Jack Coats, Chief Executive Officer ... A. Breukelman has been named to the company’s Board ... the first fully integrated version of its Multiparametric Strain ... the three-dimensional motion of the heart that is acquired ... at 15,300 points to the motion of a normal ...
(Date:3/3/2015)... 2015 Using an “intelligent,” rather than ... Part D prescription drug coverage plans could save Medicare ... University of Pittsburgh Graduate School of Public Health analysis ... March issue of the journal Health Affairs and build ... saved more than $5 billion in its Part D ...
(Date:3/3/2015)... 2015 Nutritional supplement e-tailer PureFormulas ... presenter at the third ecommerce Conference and Expo, ... Exhibition Centre March 10-12. , PureFormulas CMO Daniel ... 11 am (Melbourne time). His session, entitled “Tapping ... making each customer’s experience unique via personalization, as ...
Breaking Medicine News(10 mins):Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 2Health News:IU Simon Cancer Center Teams with OncLive® in Strategic Alliance Partnership 3Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 2Health News:Introducing Celestix Cloud Edge Security 2.0 for Increased Security in DirectAccess Client Management 3Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 2Health News:William A. (Bill) Breukelman Named to CardioWise, Inc. Board of Directors 3Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 2Health News:Medicare and Patients with Schizophrenia Could Save $150 Million on Part D Plans 3Health News:South Florida-based PureFormulas will discuss personalization at ecommerce Conference and Expo in Melbourne, Australia 2
... Hinestroza is working with the U.S. government to create ... industrial chemicals into harmless byproducts. , Potential applications include ... buildings and vehicles. , Hinestroza, assistant professor of fiber ... member of two teams that secured more than $2.2 ...
... many Americans eagerly,awaiting some extra cash in their pockets ... to make an investment in your health. As the,voice ... and its,3,000 members urge you to invest your newly ... more important than investing in your health?" said ISPA,President ...
... following operations for which a "prophylactic" antibiotic is given ... it was just a decade ago, according to researchers ... their findings in the June 15 issue of Clinical ... have been associated with severe infections, such as open ...
... Africa ... and Asia, WASHINGTON, May 27 ... taught us and it,represents the building block of our model to fight HIV ... People., It also is the overarching message Ms. Lichtenberg conveys in her,presentation ...
... (BRONX, NY) The Albert Einstein College of Medicine ... of more than $8.5 million from the National Institutes ... Einstein-Montefiore Center for AIDS Research (CFAR) at Einstein and ... that together conduct some of the most important, fundamental ...
... May 27 The Academy of General,Dentistry (AGD) ... Act of 2008" by Sen. Benjamin Cardin (D-MD) ... proposes the establishment of a,multi-faceted approach to oral ... health working group to assess existing federal oral ...
Cached Medicine News:Health News:Cornell receives federal grants to create fabrics to render toxic chemicals harmless 2Health News:Invest in Your Future With a Spa Visit Today 2Health News:Invest in Your Future With a Spa Visit Today 3Health News:The balance shifts 2Health News:Successful Community-Driven Efforts Against HIV/AIDS Highlighted in Conference Panel 2Health News:Einstein-Montefiore Center for AIDS Research receives $8.5M award from NIH 2Health News:Einstein-Montefiore Center for AIDS Research receives $8.5M award from NIH 3Health News:AGD Applauds Sen. Cardin Oral Health Initiative Bill; Urges All Senators to Co-Sponsor Measure 2
... device the two steps are performed in ... Proteus' single use disposable cartridge and placed ... operator touches a button, and the cycle ... centrifugation. Then the integral syringe pump concentrates ...
Avitene Microfibrillar Collagen (MCH) is used in surgical procedures as an adjunct to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
Avitene Microfibrillar Collagen Hemostat (MCH) is used in surgical procedures as an to hemostasis when control of bleeding by ligature or conventional procedures is ineffective or impractical....
... based upon the physiological form and ... segment unit. Kinematics and morphology of ... and anatomical aspects of the physiological ... components utilizing proven implant materials: Forged ...
Medicine Products: